180 studies found for:    "Osteoporosis, Postmenopausal"
Show Display Options
Rank Status Study
21 Completed BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
22 Completed SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
23 Completed
Has Results
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
24 Completed
Has Results
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
25 Completed A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Condition: Post-Menopausal Osteoporosis
Interventions: Drug: ibandronate [Bonviva/Boniva];   Drug: Risedronate
26 Completed A Study of Adherence to Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP).
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
27 Active, not recruiting Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Bazedoxifene;   Drug: Calcium/Vit D
28 Recruiting Radius Loading in Primary Hyperparathyroidism
Conditions: Hyperparathyroidism, Primary;   Bone Diseases, Metabolic;   Osteoporosis, Postmenopausal;   Bone Loss, Postmenopausal
Interventions: Other: Forearm exercise program;   Other: Walking program
29 Recruiting Wellnara Post-marketing Surveillance in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2/LNG oral (Wellnara, BAY86-5029)
30 Completed Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate (HMR4003)
31 Completed Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Intervention: Drug: Teriparatide
32 Active, not recruiting Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 785;   Drug: Placebo
33 Completed Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Bazedoxifene;   Drug: Placebo
34 Active, not recruiting Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
Condition: Post-menopausal Osteoporosis
Interventions: Drug: Ibandronate;   Drug: Risedronate;   Drug: Alendronate
35 Completed Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women
Condition: Osteoporosis Postmenopausal
Intervention: Drug: Risedronate (HMR4003)
36 Recruiting Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Liuwei Dihuang Pills
37 Completed
Has Results
A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: denosumab;   Drug: placebo
38 Completed Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: teriparatide;   Drug: Placebo;   Drug: Calcium Supplement;   Drug: Vitamin D Supplement
39 Terminated Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Risedronate;   Drug: Raloxifene;   Other: Placebo
40 Completed OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate sodium

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years